Abstract
Objective
We analyze a large population of patients to determine whether gamma glutamyl transferase (GGT) levels are increased in sleep apnea-hypopnea syndrome (OSA) and whether these levels are related to clinical characteristics or polygraphic indexes.
Methods
A cross-sectional study in a population of 1744 patients referred for OSA suspicion was conducted. The following variables were determined: glucose, cholesterol, triglycerides, aspartate aminotransferase (GOT), alanine aminotransferase (GPT), GGT, body mass index, waist-hip ratio (WHR), and overnight sleep study.
Results
The 483 patients with GGT ≥40 IU/l were younger and more obese, and had a pattern of more centrally distributed fat than the 1261 with GGT <40 IU/l. Patients with high levels of GGT also consumed more alcohol, had a poorer biochemical profile, and had more respiratory and oximetric alterations during sleep. GGT levels were significantly correlated with AHI, DI, and CT90. In the binary regression test, WHR, glucose, cholesterol, triglycerides, and grams of alcohol consumed per day predicted GGT levels ≥40 IU/l, while none of the polygraphic variables had predictive value.
Conclusions
High GGT levels were associated with the severity of OSA. However, this relationship seems to be due to the coexistence of other associated factors, mainly central obesity, rather than to the respiratory disorders found in this disease.
Similar content being viewed by others
References
Lee DH, Gross M, Jacobs DR (2004) Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the Cardiovascular Risk Development in Young Adults (CARDIA) Study. Clin Chem 50:582–588
Lee DH, Jacobs DR Jr, Gross M et al (2003) Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49:1358–1366
Lee DS, Evans JC, Robins SJ et al (2007) Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27:127–133
Gozal D, Kheirandish-Gozal L (2008) Cardiovascular morbidity in obstructive sleep apnea. Oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 177:369–375
Lavie L (2003) Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 7:35–51
Schulz R, Mahmoudi S, Hattar K et al (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566–570
Lee SD, Ju G, Choi JA, Kim JW, Yoon IY (2012) The association of oxidative stress with central obesity in obstructive sleep apnea. Sleep Breath 16:511–517
Mancuso M, Bonanni E, LoGerfo A et al (2012) Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med 13:632–636
Devulapally K, Pongonis R, Khayat R (2009) OSA: the new cardiovascular disease: part II: overview of cardiovascular diseases associated with obstructive sleep apnea. Heart Fail Rev 14:155–164
Barceló A, Barbé F, de la Peña M et al (2006) Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27:756–760
Kanbay A, Kaya E, Buyukoglan H et al (2011) Serum gamma-glutamyl transferase activity is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. Respir Med 105:637–642
Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645
Iber C, Ancoli-Israel S, Chesson A, Quan SF, for the American Academy of Sleep Medicine (2007) The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, 1st edn. American Academy of Sleep Medicine, Westchester
Ruttmann E, Brant LJ, Concin H, Health Monitoring and Promotion Program Study Group et al (2005) Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 112:2130–2137
Meisinger C, Döring A, Schneider A, Löwel H, KORA Study Group (2006) Serum gammaglutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 189:297–302
Stojakovic T, Scharnagl H, Trauner M et al (2010) Serum gammaglutamyl transferase and mortality in persons undergoing coronary angiography—The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 208(2):564–571
Barcelo A, Miralles C, Barbe F, Vila M, Pons S, Agusti AG (2000) Abnormal lipid peroxidation in patients with sleep apnea. Eur Respir J 16:644–647
Song SH, Kwak IS, Kim YJ et al (2007) Can γ-glutamyltransferase be an additional marker of arterial stiffness? Circ J 71:1715–1720
García-Díaz E, Quintana-Gallego E, Ruiz A, Carmona-Bernal C, Sánchez-Armengol A, Botebol-Benhamou G, Capote F (2007) Respiratory polygraphy with actigraphy in the diagnosis of sleep apnea-hypopnea syndrome. Chest 131:725–732
Kawamoto R, Kohara K, Tabara Y, Miki T, Otsuka N (2009) Serum gamma-glutamyl transferase levels are associated with metabolic syndrome in community-dwelling individuals. J Atheroscler Thromb 16(4):355–362
Punjabi NM, Caffo BS, Goodwin JL et al (2009) Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 6(8):e1000132
Christou K, Kostikas K, Pastaka C, Tanou K, Antoniadou I, Gourgoulianis KI (2009) Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med 10(1):87–94
Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053
Young T, Finn L, Peppard PE et al (2008) Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31:1071–1078
Rodríguez-Rodríguez E, Perea JM, López-Sobaler AM, Ortega RM (2009) Obesity, insulin resistance and increase in adipokines levels: importance of the diet and the physical activity. Nutr Hosp 24:415–421
Conflict of interest
None of the authors have any conflict of interest with the subject matter or materials discussed in the manuscript here reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sánchez-Armengol, A., Villalobos-López, P., Caballero-Eraso, C. et al. Gamma glutamyl transferase and oxidative stress in obstructive sleep apnea: a study in 1744 patients. Sleep Breath 19, 883–890 (2015). https://doi.org/10.1007/s11325-014-1115-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-014-1115-5